Request Free Sample ×
ReportInfographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

India Epilepsy Surgery Market

ID: MRFR/HC/51355-HCR
200 Pages
Rahul Gotadki
Last Updated: February 06, 2026

India Epilepsy Surgery Market Research Report By Procedure Type (Respective Surgery, Laser Interstitial Thermal Therapy (LITT)) and By End User (Hospitals & Clinics, Specialty Centers) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

India Epilepsy Surgery Market Infographic
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Healthcare, BY Surgery Type (USD Million)
      1. 4.1.1 Resective Surgery
      2. 4.1.2 Functional Surgery
      3. 4.1.3 Lesionectomy
      4. 4.1.4 Hemispherectomy
    2. 4.2 Healthcare, BY Indication (USD Million)
      1. 4.2.1 Drug-resistant Epilepsy
      2. 4.2.2 Focal Epilepsy
      3. 4.2.3 Generalized Epilepsy
      4. 4.2.4 Neurodegenerative Disorders
    3. 4.3 Healthcare, BY Patient Age Group (USD Million)
      1. 4.3.1 Pediatric
      2. 4.3.2 Adolescent
      3. 4.3.3 Adult
      4. 4.3.4 Geriatric
    4. 4.4 Healthcare, BY Surgical Technique (USD Million)
      1. 4.4.1 Open Surgery
      2. 4.4.2 Minimally Invasive Surgery
      3. 4.4.3 Laser Ablation
      4. 4.4.4 Stereotactic Surgery
    5. 4.5 Healthcare, BY Postoperative Care (USD Million)
      1. 4.5.1 Inpatient Care
      2. 4.5.2 Outpatient Care
      3. 4.5.3 Rehabilitation Services
      4. 4.5.4 Follow-up Monitoring
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Healthcare
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Medtronic (IN)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Johnson & Johnson (IN)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Stryker (IN)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Boston Scientific (IN)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Abbott Laboratories (IN)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 NeuroPace (IN)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 LivaNova (IN)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Nico Corporation (IN)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 Integra LifeSciences (IN)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 INDIA MARKET ANALYSIS BY SURGERY TYPE
    3. 6.3 INDIA MARKET ANALYSIS BY INDICATION
    4. 6.4 INDIA MARKET ANALYSIS BY PATIENT AGE GROUP
    5. 6.5 INDIA MARKET ANALYSIS BY SURGICAL TECHNIQUE
    6. 6.6 INDIA MARKET ANALYSIS BY POSTOPERATIVE CARE
    7. 6.7 KEY BUYING CRITERIA OF HEALTHCARE
    8. 6.8 RESEARCH PROCESS OF MRFR
    9. 6.9 DRO ANALYSIS OF HEALTHCARE
    10. 6.10 DRIVERS IMPACT ANALYSIS: HEALTHCARE
    11. 6.11 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    12. 6.12 SUPPLY / VALUE CHAIN: HEALTHCARE
    13. 6.13 HEALTHCARE, BY SURGERY TYPE, 2024 (% SHARE)
    14. 6.14 HEALTHCARE, BY SURGERY TYPE, 2024 TO 2035 (USD Million)
    15. 6.15 HEALTHCARE, BY INDICATION, 2024 (% SHARE)
    16. 6.16 HEALTHCARE, BY INDICATION, 2024 TO 2035 (USD Million)
    17. 6.17 HEALTHCARE, BY PATIENT AGE GROUP, 2024 (% SHARE)
    18. 6.18 HEALTHCARE, BY PATIENT AGE GROUP, 2024 TO 2035 (USD Million)
    19. 6.19 HEALTHCARE, BY SURGICAL TECHNIQUE, 2024 (% SHARE)
    20. 6.20 HEALTHCARE, BY SURGICAL TECHNIQUE, 2024 TO 2035 (USD Million)
    21. 6.21 HEALTHCARE, BY POSTOPERATIVE CARE, 2024 (% SHARE)
    22. 6.22 HEALTHCARE, BY POSTOPERATIVE CARE, 2024 TO 2035 (USD Million)
    23. 6.23 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 India MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY SURGERY TYPE, 2026-2035 (USD Million)
      2. 7.2.2 BY INDICATION, 2026-2035 (USD Million)
      3. 7.2.3 BY PATIENT AGE GROUP, 2026-2035 (USD Million)
      4. 7.2.4 BY SURGICAL TECHNIQUE, 2026-2035 (USD Million)
      5. 7.2.5 BY POSTOPERATIVE CARE, 2026-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

India Healthcare Market Segmentation

Healthcare By Surgery Type (USD Million, 2026-2035)

  • Resective Surgery
  • Functional Surgery
  • Lesionectomy
  • Hemispherectomy

Healthcare By Indication (USD Million, 2026-2035)

  • Drug-resistant Epilepsy
  • Focal Epilepsy
  • Generalized Epilepsy
  • Neurodegenerative Disorders

Healthcare By Patient Age Group (USD Million, 2026-2035)

  • Pediatric
  • Adolescent
  • Adult
  • Geriatric

Healthcare By Surgical Technique (USD Million, 2026-2035)

  • Open Surgery
  • Minimally Invasive Surgery
  • Laser Ablation
  • Stereotactic Surgery

Healthcare By Postoperative Care (USD Million, 2026-2035)

  • Inpatient Care
  • Outpatient Care
  • Rehabilitation Services
  • Follow-up Monitoring

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories
Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓